Retatrutide Phase 2 Trial Explores Efficacy in Obesity Without Diabetes | Retatrutide News

A Phase 2 trial is evaluating retatrutide in obese or overweight adults without type 2 diabetes. This study assesses its efficacy alongside diet and exe...
Clinical Trials · October 16, 2026